MedPath
HSA Approval

DALACIN T LOTION 1%

SIN07338P

DALACIN T LOTION 1%

DALACIN T LOTION 1%

February 11, 1993

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

LOTION

**DOSAGE AND ADMINISTRATION** Apply a thin film of DALACIN T Lotion to the affected area of clean, dry skin twice daily. Massage into the skin is not needed. Contact with eyes and mouth should be avoided. Rinse hands after application. Dalacin T Lotion should be shaken immediately before using.

TOPICAL

Medical Information

**INDICATIONS** DALACIN T Lotion is indicated in the treatment of acne vulgaris.

**CONTRAINDICATIONS** DALACIN T is contraindicated in individuals with a history of hypersensitivity to clindamycin or lincomycin, or a history of antibiotic-associated colitis.

D10AF01

clindamycin

Manufacturer Information

PFIZER PRIVATE LIMITED

Pfizer Manufacturing Belgium NV

Pharmacia & Upjohn Company LLC

Active Ingredients

CLINDAMYCIN PHOSPHATE EQV CLINDAMYCIN

1%

Clindamycin

Documents

Package Inserts

Dalacin Soln & Lot PI.pdf

Approved: January 30, 2019

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DALACIN T LOTION 1% - HSA Approval | MedPath